These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22709002)

  • 1. Anticancer drug design using scaffolds of β-lactams, sulfonamides, quinoline, quinoxaline and natural products. Drugs advances in clinical trials.
    Balderas-Renteria I; Gonzalez-Barranco P; Garcia A; Banik BK; Rivera G
    Curr Med Chem; 2012; 19(26):4377-98. PubMed ID: 22709002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphonamido-quinoxalines: search for anticancer agent.
    Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
    Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Lactams as promising anticancer agents: Molecular hybrids, structure activity relationships and potential targets.
    Fu DJ; Zhang YF; Chang AQ; Li J
    Eur J Med Chem; 2020 Sep; 201():112510. PubMed ID: 32592915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
    Yurttaş L; Çiftçi GA
    Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents.
    Al-Dosari MS; Ghorab MM; Al-Said MS; Nissan YM
    Chem Pharm Bull (Tokyo); 2013; 61(1):50-8. PubMed ID: 23302586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity.
    El Newahie AM; Ismail NS; Abou El Ella DA; Abouzid KA
    Arch Pharm (Weinheim); 2016 May; 349(5):309-26. PubMed ID: 27062086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of quinoline as a privileged scaffold in cancer drug discovery.
    Musiol R
    Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in research of natural and synthetic bioactive quinolines.
    Chung PY; Bian ZX; Pun HY; Chan D; Chan AS; Chui CH; Tang JC; Lam KH
    Future Med Chem; 2015; 7(7):947-67. PubMed ID: 26061110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer and antiviral sulfonamides.
    Scozzafava A; Owa T; Mastrolorenzo A; Supuran CT
    Curr Med Chem; 2003 Jun; 10(11):925-53. PubMed ID: 12678681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in β-lactam Derivatives as Potential Anticancer Agents.
    Zhang X; Jia Y
    Curr Top Med Chem; 2020; 20(16):1468-1480. PubMed ID: 32148196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An insight into medicinal chemistry of anticancer quinoxalines.
    Kaushal T; Srivastava G; Sharma A; Singh Negi A
    Bioorg Med Chem; 2019 Jan; 27(1):16-35. PubMed ID: 30502116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
    Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
    Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optically active 1,3,4,4-tetrasubstituted β-lactams: synthesis and evaluation as tumor cell growth inhibitors.
    Pérez-Faginas P; Aranda MT; García-López MT; Francesch A; Cuevas C; González-Muñiz R
    Eur J Med Chem; 2011 Oct; 46(10):5108-19. PubMed ID: 21885166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents.
    Sharma V; Mehta DK; Das R
    Mini Rev Med Chem; 2017; 17(16):1557-1572. PubMed ID: 28494729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides.
    Chibale K; Ojima I; Haupt H; Geng X; Pera P; Bernacki RJ
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2457-60. PubMed ID: 11549446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
    Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives.
    Marciniec K; Pawełczak B; Latocha M; Skrzypek L; Maciążek-Jurczyk M; Boryczka S
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28212337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties.
    Palluotto F; Sosic A; Pinato O; Zoidis G; Catto M; Sissi C; Gatto B; Carotti A
    Eur J Med Chem; 2016 Nov; 123():704-717. PubMed ID: 27521587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.